Company Filing History:
Years Active: 2003-2013
Title: Michael Fox: Innovator in Pharmaceutical Compositions
Introduction
Michael Fox is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work focuses on developing stable pharmaceutical compositions that enhance the efficacy and shelf-life of various medications.
Latest Patents
Among his latest patents, Michael has developed stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids. These compositions are designed to maintain excellent storage stability, even when the active components are susceptible to degradation in acidic environments. The stabilized pharmaceutical composition includes a ring-opened 7-substituted-3,5-dihydroxyheptanoic or a ring-opened 7-substituted-3,5-dihydroxyheptenoic acid, or a pharmaceutically acceptable salt thereof, as an active component. Additionally, it incorporates a stabilizing effective amount of at least one amido-group containing polymeric compound or at least one amino-group containing polymeric compound. Notably, this composition does not require a stabilizing effective amount of another stabilizer or a combination of other stabilizers. Furthermore, he has also worked on a stable pharmaceutical formulation of paroxetine hydrochloride anhydrous, which includes specific binders and fillers prepared by the wet granulation method.
Career Highlights
Michael Fox is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His innovative work has positioned him as a key player in the development of pharmaceutical formulations that are both effective and stable.
Collaborations
Michael has collaborated with notable colleagues such as Ivo Dorossiev and Rakefet Cohen, contributing to the advancement of pharmaceutical sciences through teamwork and shared expertise.
Conclusion
Michael Fox's contributions to pharmaceutical innovations demonstrate his commitment to improving medication stability and efficacy. His patents reflect a deep understanding of the complexities involved in pharmaceutical formulations, making him a valuable asset to the industry.